BRIEF-Ariad Pharmaceuticals completes strategic review, reaffirms 2016 outlook
June 17, 2016 at 13:18 PM EDT
* Outcomes of strategic review includes significant reduction in company's expense base
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.